SARS-CoV-2-RBD
€488.00
SARS-CoV-2-RBD
Background
This product contains the receptor binding domain (RBD) of the spike glycoprotein protein (S-protein) of the SARS-CoV-2 corona virus. Infection with this virus causes COVID-19 disease. The spike protein is the common target for neutralizing antibodies and vaccines… Learn more
Production platform: This product has been produced in HEK293 cells using the rPEx™ recombinant protein production platform.
Catalog #: S015
Quantity: 100 μg
Datasheet: Lot 4229
Certificate of Analysis: Lot 4229
Contact products@ipatherapeutics.com if you have any questions